Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 11-12, 2006, Pages 1025-1037

  Rakhit, Rishi ^a   Chakrabartty, Avijit ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Familial amyotrophic lateral sclerosis; Metalloprotein; Protein folding; Protein misfolding; Protein structure; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ENZYME ACTIVITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BINDING SITES; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; MUTATION; OXIDATION-REDUCTION; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SUPEROXIDE DISMUTASE;

EID: 33751212177     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.05.004     Document Type: Review

References (141)

1. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
2. Majoor-Krakauer D., Willems P.J., and Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin. Genet. 63 (2003) 83-101
3. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D.A., Kwiatkowski T., Hosler B.A., Sagie T., Skaug J., Nasir J., Brown Jr. R.H., Scherer S.W., Rouleau G.A., Hayden M.R., and Ikeda J.E. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29 (2001) 166-173
4. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., and Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75 (2004) 822-831
5. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown R.H., and Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 38 (2006) 411-413
6. PubMed search for "superoxide dismutase" AND "amyotrophic lateral sclerosis", March 2006.
7. Raha S., and Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 25 (2000) 502-508
8. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
9. Klug D., Rabani J., and Fridovich I. A direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis. J. Biol. Chem. 247 (1972) 4839-4842
10. Crapo J.D., McCord J.M., and Fridovich I. Preparation and assay of superoxide dismutases. Methods Enzymol. 53 (1978) 382-393
11. Markowitz H., Cartwright G.E., and Wintrobe M.M. Studies on copper metabolism. XXVII. The isolation and properties of an erythrocyte cuproprotein (erythrocuprein). J. Biol. Chem. 234 (1959) 40-45
12. Lippard S.J. Principles of Bioinorganic Chemistry (1994), University Science Books
13. Quick K.L., Hardt J.I., and Dugan L.L. Rapid microplate assay for superoxide scavenging efficiency. J. Neurosci. Methods 97 (2000) 139-144
14. Salvemini D., Wang Z.Q., Zweier J.L., Samouilov A., Macarthur H., Misko T.P., Currie M.G., Cuzzocrea S., Sikorski J.A., and Riley D.P. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 286 (1999) 304-306
15. Liao Z., Liu W., Liu J., Jiang Y., Shi J., and Liu C. A study on superoxide dismutase activity of some model compounds. J. Inorg. Biochem. 55 (1994) 165-174
16. Hart P.J., Balbirnie M.M., Ogihara N.L., Nersissian A.M., Weiss M.S., Valentine J.S., and Eisenberg D. A structure-based mechanism for copper-zinc superoxide dismutase. Biochemistry 38 (1999) 2167-2178
17. Tainer J.A., Getzoff E.D., Beem K.M., Richardson J.S., and Richardson D.C. Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. J. Mol. Biol. 160 (1982) 181-217
18. Goodsell D.S., and Olson A.J. Structural symmetry and protein function. Annu. Rev. Biophys. Biomol. Struct. 29 (2000) 105-153
19. Lepock J.R., Arnold L.D., Torrie B.H., Andrews B., and Kruuv J. Structural analyses of various Cu2+, Zn2+-superoxide dismutases by differential scanning calorimetry and Raman spectroscopy. Arch. Biochem. Biophys. 241 (1985) 243-251
20. Forman H.J., and Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J. Biol. Chem. 248 (1973) 2645-2649
21. Battistoni A., Folcarelli S., Cervoni L., Polizio F., Desideri A., Giartosio A., and Rotilio G. Role of the dimeric structure in Cu,Zn superoxide dismutase. pH-dependent, reversible denaturation of the monomeric enzyme from Escherichia coli. J. Biol. Chem. 273 (1998) 5655-5661
22. Ferraroni M., Rypniewski W., Wilson K.S., Viezzoli M.S., Banci L., Bertini I., and Mangani S. The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisited. J. Mol. Biol. 288 (1999) 413-4126
23. Beyer Jr. W.F., Fridovich I., Mullenbach G.T., and Hallewell R. Examination of the role of arginine-143 in the human copper and zinc superoxide dismutase by site-specific mutagenesis. J. Biol. Chem. 262 (1987) 11182-11187
24. Banci L., Bertini I., Chiu C.Y., Mullenbach G.T., and Viezzoli M.S. Synthesis and characterization of a monomeric mutant Cu/Zn superoxide dismutase with partially reconstituted enzymic activity. Eur. J. Biochem. 234 (1995) 855-860
25. Chillemi G., Falconi M., Amadei A., Zimatore G., Desideri A., and Di Nola A. The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication. Biophys. J. 73 (1997) 1007-1018
26. Richardson J.S., Richardson D.C., Thomas K.A., Silverton E.W., and Davies D.R. Similarity of three-dimensional structure between the immunoglobulin domain and the copper, zinc superoxide dismutase subunit. J. Mol. Biol. 102 (1976) 221-235
27. Valentine J.S., Doucette P.A., and Potter S.Z. Copper-Zinc Superoxide Dismutase and Amyotrophic Lateral Sclerosis. Annu. Rev. Biochem. 74 (2005) 563-593
28. Boissinot M., Karnas S., Lepock J.R., Cabelli D.E., Tainer J.A., Getzoff E.D., and Hallewell R.A. Function of the Greek key connection analysed using circular permutants of superoxide dismutase. EMBO J. 16 (1997) 2171-2178
29. McLachlan A.D. Repeated folding pattern in copper-zinc superoxide dismutase. Nature 285 (1980) 267-268
30. Furukawa Y., and O'Halloran V. T, ALS mutations have the greatest destabilizing effect on the apo, reduced form of SOD1, leading to unfolding and oxidative aggregation. J. Biol. Chem. 280 17 (2005) 17266-17274
31. Banci L., Bertini I., Cabelli D.E., Hallewell R.A., Tung J.W., and Viezzoli M.S. A characterization of copper/zinc superoxide dismutase mutants at position 124. Zinc-deficient proteins. Eur. J. Biochem. 196 (1991) 123-128
32. Shriver D.F., Atkins P.W., and Langford C.H. Inorganic chemistry. 2nd ed. (1994), Oxford Univ. Press, Oxford
33. Verhagen M.F., Meussen E.T., and Hagen W.R. On the reduction potentials of Fe and Cu-Zn containing superoxide dismutases. Biochim. Biophys Acta 1244 (1995) 99-103
34. Liochev S.I., and Fridovich I. Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase. J. Biol. Chem. 275 (2000) 38482-38485
35. Tainer J.A., Getzoff E.D., Richardson J.S., and Richardson D.C. Structure and mechanism of copper, zinc superoxide dismutase. Nature 306 (1983) 284-287
36. Getzoff E.D., Tainer J.A., Weiner P.K., Kollman P.A., Richardson J.S., and Richardson D.C. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature 306 (1983) 287-290
37. Getzoff E.D., Cabelli D.E., Fisher C.L., Parge H.E., Viezzoli M.S., Banci L., and Hallewell R.A. Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature 358 (1992) 347-351
38. Murphy L.M., Strange R.W., and Hasnain S.S. A critical assessment of the evidence from XAFS and crystallography for the breakage of the imidazolate bridge during catalysis in CuZn superoxide dismutase. Structure 5 (1997) 371-379
39. Blumberg W.E., Peisach J., Eisenberger P., and Fee J.A. Superoxide dismutase, a study of the electronic properties of the copper and zinc by X-ray absorption spectroscopy. Biochemistry 17 (1978) 1842-1846
40. Kay L.E. Protein dynamics from NMR. Nat. Struct. Biol. 5 (1998) 513-517 (Suppl.)
41. Falconi M., Stroppolo M.E., Cioni P., Strambini G., Sergi A., Ferrario M., and Desideri A. Dynamics-function correlation in Cu, Zn superoxide dismutase: a spectroscopic and molecular dynamics simulation study. Biophys. J. 80 (2001) 2556-2567
42. Khare S.D., and Dokholyan N.V. Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3147-3152
43. Shipp E.L., Cantini F., Bertini I., Valentine J.S., and Banci L. Dynamic properties of the G93A mutant of copper-zinc superoxide dismutase as detected by NMR spectroscopy: implications for the pathology of familial amyotrophic lateral sclerosis. Biochemistry 42 (2003) 1890-1899
44. Banci L., Bertini I., Cramaro F., Del Conte R., and Rosato A. Viezzoli, Backbone dynamics of human Cu,Zn superoxide dismutase and of its monomeric F50E/G51E/E133Q mutant: the influence of dimerization on mobility and function. Biochemistry 39 (2000) 9108-9118
45. Banci L., Felli I.C., and Kummerle R. Direct detection of hydrogen bonds in monomeric superoxide dismutase: biological implications. Biochemistry 41 (2002) 2913-2920
46. Banci L., Bertini I., Del Conte R., Fadin R., Mangani S., and Viezzoli M.S. The solution structure of a monomeric, reduced form of human copper,zinc superoxide dismutase bearing the same charge as the native protein. J. Biol. Inorg. Chem. 4 (1999) 795-803
47. Banci L., Benedetto M., Bertini I., Del Conte R., Piccioli M., and Viezzoli M.S. Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme. Biochemistry 37 (1998) 11780-11791
48. Richardson J.S., and Richardson D.C. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2754-2759
49. Rosato N., Gratton E., Mei G., and Finazzi-Agro A. Fluorescence lifetime distributions in human superoxide dismutase. Effect of temperature and denaturation. Biophys J. 58 (1990) 817-822
50. Mei G., Rosato N., Silva Jr. N., Rusch R., Gratton E., Savini I., and Finazzi-Agro A. Denaturation of human Cu/Zn superoxide dismutase by guanidine hydrochloride: a dynamic fluorescence study. Biochemistry 31 (1992) 7224-7230
51. Silva Jr. N., Gratton E., Mei G., Rosato N., Rusch R., and Finazzi-Agro A. Molten globule monomers in human superoxide dismutase. Biophys. Chem. 48 (1993) 171-182
52. Rumfeldt J.A., Stathopulos P.B., Chakrabarrty A., Lepock J.R., and Meiering E.M. Mechanism and thermodynamics of guanidinium chloride-induced denaturation of ALS-associated mutant Cu Zn superoxide dismutases. J. Mol. Biol. 355 (2006) 106-123
53. Stathopulos P.B., Rumfeldt J.A., Karbassi F., Siddall C.A., Lepock J.R., and Meiering E.M. Calorimetric analysis of thermodynamic stability and aggregation for Apo and Holo amyotrophic lateral sclerosis-associated Gly-93 mutants of superoxide dismutase. J. Biol. Chem. 281 (2006) 6184-6193
54. Fassbender K., Masters C., and Beyreuther K. Alzheimer's disease: molecular concepts and therapeutic targets. Naturwissenschaften 88 (2001) 261-267
55. Outten C.E., and O'Halloran T.V. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science 292 (2001) 2488-2492
56. Rae T.D., Schmidt P.J., Pufahl R.A., Culotta V.C., and O'Halloran T.V. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284 (1999) 805-808
57. Culotta V.C., Klomp L.W., Strain J., Casareno R.L., Krems B., and Gitlin J.D. The copper chaperone for superoxide dismutase. J. Biol. Chem. 272 (1997) 23469-23472
58. Lamb A.L., Torres A.S., O'Halloran T.V., and Rosenzweig A.C. Heterodimeric structure of superoxide dismutase in complex with its metallochaperone. Nat. Struct Biol. 8 (2001) 751-755
59. Hall L.T., Sanchez R.J., Holloway S.P., Zhu H., Stine J.E., Lyons T.J., Demeler B., Schirf V., Hansen J.C., Nersissian A.M., Valentine J.S., and Hart P.J. X-ray crystallographic and analytical ultracentrifugation analyses of truncated and full-length yeast copper chaperones for SOD (LYS7): a dimer-dimer model of LYS7-SOD association and copper delivery. Biochemistry 39 (2000) 3611-3623
60. Subramaniam J.R., Lyons W.E., Liu J., Bartnikas T.B., Rothstein J., Price D.L., Cleveland D.W., Gitlin J.D., and Wong P.C. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5 (2002) 301-307
61. Carroll M.C., Girouard J.B., Ulloa J.L., Subramaniam J.R., Wong P.C., Valentine J.S., and Culotta V.C. Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5964-5969
62. Jensen L.T., and Culotta V.C. Activation of CuZn superoxide dismutases from Caenorhabditis elegans does not require the copper chaperone CCS. J. Biol. Chem. 280 (2005) 41373-41379
63. Arnesano F., Banci L., Bertini I., Martinelli M., Furukawa Y., and O'Halloran T.V. The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J. Biol. Chem. 279 (2004) 47998-48003
64. Lindberg M.J., Normark J., Holmgren A., and Oliveberg M. Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15893-15898
65. Tiwari A., and Hayward L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 278 (2003) 5984-5992
66. Furukawa Y., Torres A.S., and O'Halloran T.V. Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J. 23 (2004) 2872-2881
67. The tight regulation of intracellular zinc homeostasis at femtomolar concentrations has been observed in E. coli`; the regulation of zinc transport in mammalian cells is unknown, but is likely similar.
68. Pardo C.A., Xu Z., Borchelt D.R., Price D.L., Sisodia S.S., and Cleveland D.W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 954-958
69. Bartnikas T.B., and Gitlin J.D. Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase. J. Biol. Chem. 278 (2003) 33602-33608
70. Brown N.M., Torres A.S., Doan P.E., and O'Halloran T.V. Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu,Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5518-5523
71. Tower J. There's a problem in the furnace. Sci. Aging Knowledge Environ. (2004) pe1
72. Borchelt D.R., Lee M.K., Slunt H.S., Guarnieri M., Xu Z.S., Wong P.C., Brown Jr. R.H., Price D.L., Sisodia S.S., and Cleveland D.W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8292-8296
73. Ratovitski T., Corson L.B., Strain J., Wong P., Cleveland D.W., Culotta V.C., and Borchelt D.R. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum. Mol. Genet. 8 (1999) 1451-1460
74. Borchelt D.R., Guarnieri M., Wong P.C., Lee M.K., Slunt H.S., Xu Z.S., Sisodia S.S., Price D.L., and Cleveland D.W. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem. 270 (1995) 3234-3238
75. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
76. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Clevel D.W., and Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
77. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
78. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown Jr. R.H., Scott R.W., and Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13 (1996) 43-47
79. Yim M.B., Chock P.B., and Stadtman E.R. Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5006-5010
80. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 (1996) 515-518
81. Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., and Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5709-5714
82. Yim H.S., Kang J.H., Chock P.B., Stadtman E.R., and Yim M.B. A familial amyotrophic lateral sclerosis-associated A4(V Cu, Zn-superoxide dismutase mutant has a lower Km for hydrogen peroxide. Correlation between clinical severity and the Km value. J. Biol. Chem. 272 (1997) 8861-8863
83. Uchida K., and Kawakishi S. Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J. Biol. Chem. 269 (1994) 2405-2410
84. Jewett S.L., Rocklin A.M., Ghanevati M., Abel J.M., and Marach J.A. A new look at a time-worn system: oxidation of CuZn-SOD by H2O2. Free Radical Biol. Med. 26 (1999) 905-918
85. Sampson J.B., and Beckman J.S. Hydrogen peroxide damages the zinc-binding site of zinc-deficient Cu Zn superoxide dismutase. Arch. Biochem. Biophys. 392 (2001) 8-13
86. Goss S.P., Singh R.J., and Kalyanaraman B. Bicarbonate enhances the peroxidase activity of Cu,Zn-superoxide dismutase. Role of carbonate anion radical. J. Biol. Chem. 274 (1999) 28233-28239
87. Liochev S.I., and Fridovich I. On the role of bicarbonate in peroxidations catalyzed by Cu Zn superoxide dismutase. Free Radical Biol. Med. 27 (1999) 1444-1447
88. Liochev S.I., and Fridovich I. CO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 743-744
89. Blough N.V., and Zafiriou O.C. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg. Chem. 24 (1985) 3502-3504
90. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
91. Beckman J.S., Carson M., Smith C.D., and Koppenol W.H. ALS, SOD and peroxynitrite. Nature 364 (1993) 584
92. Crow J.P., Sampson J.B., Zhuang Y., Thompson J.A., and Beckman J.S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69 (1997) 1936-1944
93. Estevez A.G., Crow J.P., Sampson J.B., Reiter C., Zhuang Y., Richardson G.J., Tarpey M.M., Barbeito L., and Beckman J.S. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286 (1999) 2498-2500
94. Liochev S.I., and Fridovich I. Superoxide and nitric oxide: consequences of varying rates of production and consumption: a theoretical treatment. Free Radical Biol. Med. 33 (2002) 137-141
95. Bruijn L.I., Beal M.F., Becher M.W., Schulz J.B., Wong P.C., Price D.L., and Cleveland D.W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7606-7611
96. Peluffo H., Shacka J.J., Ricart K., Bisig C.G., Martinez-Palma L., Pritsch O., Kamaid A., Eiserich J.P., Crow J.P., Barbeito L., and Estevez A.G. Induction of motor neuron apoptosis by free 3-nitro-l-tyrosine. J. Neurochem. 89 (2004) 602-612
97. Johnson M.A., Macdonald T.L., Mannick J.B., Conaway M.R., and Gaston B. Accelerated s-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper,zinc-superoxide dismutase. J. Biol. Chem. 276 (2001) 39872-39878
98. Schonhoff C.M., Matsuoka M., Tummala H., Johnson M.A., Estevez A.G., Wu R., Kamaid A., Ricart K.C., Hashimoto Y., Gaston B., Macdonald T.L., Xu Z., and Mannick J.B. S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2404-2409
99. Bush A.I. Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?. Nat. Neurosci. 5 (2002) 919 (author reply 919-20)
100. Wang J., Slunt H., Gonzales V., Fromholt D., Coonfield M., Copeland N.G., Jenkins N.A., and Borchelt D.R. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 12 (2003) 2753-2764
101. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic lateral sclerosis and structural defects in Cu Zn superoxide dismutase. Science 261 (1993) 1047-1051
102. For a complete history of how mutations in SOD1 was found to correlate with fALS, please see OMIM [online mendelian inheritance in man] articles 105400 and 147450 on amyotrophic lateral sclerosis and superoxide dismutase, respectively.
103. A current listing of all known mutations that cause ALS can be found at:http://alsod.org
104. Cardoso R.M., Thayer M.M., DiDonato M., Lo T.P., Bruns C.K., Getzoff E.D., and Tainer J.A. Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu Zn superoxide dismutase. J. Mol. Biol. 324 (2002) 247-256
105. Strange R.W., Antonyuk S.V., Hough M.A., Doucette P.A., Valentine J.S., and Hasnain S.S. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J. Mol. Biol. 356 (2006) 1152-1162
106. Antonyuk S., Elam J.S., Hough M.A., Strange R.W., Doucette P.A., Rodriguez J.A., Hayward L.J., Valentine J.S., Hart P.J., and Hasnain S.S. Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg. Protein Sci. 14 (2005) 1201-1213
107. Strange R.W., Antonyuk S., Hough M.A., Doucette P.A., Rodriguez J.A., Hart P.J., Hayward L.J., Valentine J.S., and Hasnain S.S. The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J. Mol. Biol. 328 (2003) 877-891
108. Elam J.S., Taylor A.B., Strange R., Antonyuk S., Doucette P.A., Rodriguez J.A., Hasnain S.S., Hayward L.J., Valentine J.S., Yeates T.O., and Hart P.J. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 10 (2003) 461-467
109. DiDonato M., Craig L., Huff M.E., Thayer M.M., Cardoso R.M., Kassmann C.J., Lo T.P., Bruns C.K., Powers E.T., Kelly J.W., Getzoff E.D., and Tainer J.A. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J. Mol. Biol. 332 (2003) 601-615
110. Rodriguez J.A., Valentine J.S., Eggers D.K., Roe J.A., Tiwari A., Brown Jr. R.H., and Hayward L.J. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J. Biol. Chem. 277 (2002) 15932-15937
111. Lindberg M.J., Tibell L., and Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16607-16612
112. Rodriguez J.A., Shaw B.F., Durazo A., Sohn S.H., Doucette P.A., Nersissian A.M., Faull K.F., Eggers D.K., Tiwari A., Hayward L.J., and Valentine J.S. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10516-10521
113. Lyons T.J., Liu H., Goto J.J., Nersissian A., Roe J.A., Graden J.A., Cafe C., Ellerby L.M., Bredesen D.E., Gralla E.B., and Valentine J.S. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12240-12244
114. Hayward L.J., Rodriguez J.A., Kim J.W., Tiwari A., Goto J.J., Cabelli D.E., Valentine J.S., and Brown Jr. R.H. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 277 (2002) 15923-15931
115. Goto J.J., Zhu H., Sanchez R.J., Nersissian A., Gralla E.B., Valentine J.S., and Cabelli D.E. Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 275 (2000) 1007-1014
116. Dafforn T.R., and Smith C.J. Natively unfolded domains in endocytosis: hooks, lines and linkers. EMBO Rep. 5 (2004) 1046-1052
117. Wood J.D., Beaujeux T.P., and Shaw P.J. Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol. 29 (2003) 529-545
118. Shibata N., Asayama K., Hirano A., and Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev. Neurosci. 18 (1996) 492-498
119. Shibata N., Hirano A., Kobayashi M., Dal Canto M.C., Gurney M.E., Komori T., Umahara T., and Asayama K. Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD. Acta Neuropathol. (Berl.) 95 (1998) 136-142
120. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.X., Hung W.Y., Kato T., and Asayama K. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55 (1996) 481-490
121. Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.F., Crow J.P., Cashman N.R., Kondejewski L.H., and Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277 (2002) 47551-47556
122. Rakhit R., Crow J.P., Lepock J.R., Kondejewski L.H., Cashman N.R., and Chakrabartty A. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279 (2004) 15499-15504
123. Andrus P.K., Fleck T.J., Gurney M.E., and Hall E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71 (1998) 2041-2048
124. Stathopulos P.B., Rumfeldt J.A., Scholz G.A., Irani R.A., Frey H.E., Hallewell R.A., Lepock J.R., and Meiering E.M. Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7021-7026
125. Khare S.D., Caplow M., and Dokholyan N.V. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15094-15099
126. Chung J., Yang H., de Beus M.D., Ryu C.Y., Cho K., and Colon W. Cu/Zn superoxide dismutase can form pore-like structures. Biochem. Biophys. Res. Commun. 312 (2003) 873-876
127. Khare S.D., Wilcox K.C., Gong P., and Dokholyan N.V. Sequence and structural determinants of Cu Zn superoxide dismutase aggregation. Proteins 61 (2005) 617-632
128. Matsumoto G., Kim S., and Morimoto R.I. Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells. J. Biol. Chem. 281 (2006) 4477-4485
129. Lee J.P., Gerin C., Bindokas V.P., Miller R., Ghadge G., and Roos R.P. No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis. J. Neurochem. 82 (2002) 1229-1238
130. Hough M.A., Grossmann J.G., Antonyuk S.V., Strange R.W., Doucette P.A., Rodriguez J.A., Whitson L.J., Hart P.J., Hayward L.J., Valentine J.S., and Hasnain S.S. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5976-5981
131. Lindberg M.J., Bystrom R., Boknas N., Andersen P.M., and Oliveberg M. Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9754-9759
132. Rakhit et al., unpublished results.
133. Hammarstrom P., Wiseman R.L., Powers E.T., and Kelly J.W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299 (2003) 713-716
134. Colon W., Lai Z., McCutchen S.L., Miroy G.J., Strang C., and Kelly J.W. FAP mutations destabilize transthyretin facilitating conformational changes required for amyloid formation. Ciba Found Symp. 199 (1996) 228-238 (discussion 239-42)
135. Lai Z., Colon W., and Kelly J.W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35 (1996) 6470-6482
136. Wiseman R.L., Johnson S.M., Kelker M.S., Foss T., Wilson I.A., and Kelly J.W. Kinetic stabilization of an oligomeric protein by a single ligand binding event. J. Am. Chem. Soc. 127 (2005) 5540-5551
137. Ray S.S., Nowak R.J., Strokovich K., Brown Jr. R.H., Walz T., and Lansbury Jr. P.T. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry 43 (2004) 4899-4905
138. Ghadge G.D., Wang L., Sharma K., Monti A.L., Bindokas V., Stevens F.J., and Roos R.P. Truncated wild-type SOD1 and FALS-linked mutant SOD1 cause neural cell death in the chick embryo spinal cord. Neurobiol. Dis. 21 (2006) 194-205
139. de Beus M.D., Chung J., and Colon W. Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties. Protein Sci. 13 (2004) 1347-1355
140. Ray S.S., Nowak R.J., Brown Jr. R.H., and Lansbury Jr. P.T. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3639-36144
141. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723